東方財富(300059.SZ):東方財富證券擬申請發行不超120億元公司債
格隆匯6月25日丨東方財富(300059.SZ)公佈,公司第五屆董事會第十三次會議審議通過了《關於子公司東方財富證券股份有限公司申請公開發行公司債券的議案》。為進一步拓寬東方財富證券股份有限公司(“東方財富證券”)融資渠道,補充流動資金,東方財富證券面向專業投資者公開發行公司債券,發行規模不超過人民幣120億元(含120億元),債券期限不超過5年(含5年)。決議有效期自東方財富證券股東大會相關議案審議通過之日起36個月內有效。
本次發行公司債券的募集資金擬用於償還到期債務以及其他符合國家有關政策的用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.